FMR LLC & Abigail Johnson Hold 7.99% Stake in Sana Bio
Ticker: SANA · Form: SC 13G/A · Filed: 2024-02-09T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, amendment, biotechnology, stake-change
TL;DR
**FMR LLC and Abigail Johnson still own 7.99% of Sana Bio, showing continued institutional backing.**
AI Summary
FMR LLC, a major investment firm, and its Chairman and CEO, Abigail P. Johnson, have updated their ownership stake in Sana Biotechnology, Inc. As of February 9, 2024, they collectively beneficially own 15,751,291 shares of common stock, representing 7.990% of the company. This filing indicates a significant, though slightly reduced, continued interest from a large institutional investor, which can signal confidence in Sana Biotechnology's long-term prospects to current and potential shareholders.
Why It Matters
Large institutional ownership by FMR LLC and Abigail P. Johnson can provide stability and a vote of confidence for Sana Biotechnology, potentially influencing other investors.
Risk Assessment
Risk Level: low — This filing indicates a stable, significant institutional ownership, which generally reduces risk by signaling confidence in the company.
Analyst Insight
Investors should note the continued, stable institutional ownership by FMR LLC and Abigail P. Johnson, which can be a positive signal, but also monitor for any future changes in their stake as an indicator of institutional sentiment.
Key Numbers
- 15,751,291 — Shares Beneficially Owned (Total common stock shares held by FMR LLC and Abigail P. Johnson in Sana Biotechnology, Inc.)
- 7.990% — Percent of Class (The percentage of Sana Biotechnology, Inc.'s common stock owned by FMR LLC and Abigail P. Johnson.)
Key Players & Entities
- FMR LLC (company) — reporting person and major investment firm
- Abigail P. Johnson (person) — reporting person, Chairman and CEO of FMR LLC
- Sana Biotechnology, Inc. (company) — the issuer of the securities
- 15,751,291 (dollar_amount) — number of shares beneficially owned
- 7.990% (dollar_amount) — percentage of class beneficially owned
- February 9, 2024 (dollar_amount) — date as of change
Forward-Looking Statements
- FMR LLC will maintain a significant, but potentially fluctuating, stake in Sana Biotechnology, Inc. over the next year. (FMR LLC) — medium confidence, target: 2025-02-09
- Sana Biotechnology, Inc. will continue to attract institutional investment due to its classification in 'BIOLOGICAL PRODUCTS'. (Sana Biotechnology, Inc.) — medium confidence, target: 2025-02-09
FAQ
Who are the primary reporting persons in this SC 13G/A filing for Sana Biotechnology, Inc.?
The primary reporting persons are FMR LLC and Abigail P. Johnson, as stated in Item 1 of the filing.
What is the total number of shares of Sana Biotechnology, Inc. common stock beneficially owned by the reporting persons?
The reporting persons, FMR LLC and Abigail P. Johnson, beneficially own a total of 15,751,291 shares of common stock, as indicated in Item 4(a) and Item 7 on the cover pages.
What percentage of Sana Biotechnology, Inc.'s common stock do the reporting persons collectively own?
FMR LLC and Abigail P. Johnson collectively own 7.990% of Sana Biotechnology, Inc.'s common stock, as shown in Item 4(b) and Item 11 on the cover pages.
What is the CUSIP number for Sana Biotechnology, Inc. common stock mentioned in the filing?
The CUSIP number for Sana Biotechnology, Inc. common stock is 799566104, as stated in Item 2(e) and on the cover page.
What rule is this Schedule 13G/A filed under?
This Schedule 13G/A is filed under Rule 13d-1(c), as indicated by the 'x' in the appropriate box on the cover page.
From the Filing
EDGAR Filing Documents for 0000315066-24-001443 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000315066-24-001443 Filing Date 2024-02-09 Accepted 2024-02-09 09:49:33 Documents 1 Document Format Files Seq Description Document Type Size 1 filing.txt SC 13G/A 6154 Complete submission text file 0000315066-24-001443.txt 7833 Mailing Address 245 SUMMER STREET BOSTON MA 02210 Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339 FMR LLC (Filed by) CIK : 0000315066 (see all company filings) EIN. : 043532603 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 0000 Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914 Sana Biotechnology, Inc. (Subject) CIK : 0001770121 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-92124 | Film No.: 24612086 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)